人福医药集团股份公司 关于公司部分董事辞职的公告

Group 1 - The board of directors of the company received resignation reports from non-independent directors Zhang Xiaodong and Wang Xuehai due to personal reasons, with Zhang continuing in other roles and Wang leaving all positions within the company [1] - The company will complete the election of new non-independent directors as per legal procedures before the expiration of the current board's term [1] - The company expresses gratitude for the contributions made by Zhang Xiaodong and Wang Xuehai during their tenure [1] Group 2 - The company announced that the second creditors' meeting for the restructuring of its controlling shareholder, Wuhan Contemporary Technology Industry Group Co., Ltd., has been postponed to February 13, 2025 [2] - The initial meeting was scheduled for January 27, 2025, but was delayed following a notification from the management team of Contemporary Technology [2][3] - The company will continue to monitor the progress of the restructuring case and fulfill its information disclosure obligations as required [3]